1. null
    Avril A. B. Robertson, 2018 CrossRef
  2. Schwann cell transplantation exerts neuroprotective roles in rat model of spinal cord injury by combating inflammasome activation and improving motor recovery and remyelination
    Mahboubeh Mousavi et al, 2019, Metab Brain Dis CrossRef
  3. Wogonoside promotes apoptosis in gastric cancer AGS and SGC‐7901 cells through induction of mitochondrial dysfunction and endoplasmic reticulum stress
    Xiao‐Miao Hu et al, 2019, FEBS Open Bio CrossRef
  4. Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice
    Wu Jiang et al, 2017, J Neuroinflammation CrossRef
  5. Targeting the NLRP3 Inflammasome in Neuroinflammation: Health Promoting Effects of Dietary Phytochemicals in Neurological Disorders
    Wei‐Lun Hung et al, 2019, Mol. Nutr. Food Res. CrossRef
  6. MCC950, a Selective Inhibitor of NLRP3 Inflammasome, Reduces the Inflammatory Response and Improves Neurological Outcomes in Mice Model of Spinal Cord Injury
    Jianhang Jiao et al, 2020, Front. Mol. Biosci. CrossRef
  7. Role of pyroptosis in spinal cord injury and its therapeutic implications.
    Abdullah Al Mamun et al, 2021, J Adv Res CrossRef
  8. The main bioactive compounds of Scutellaria baicalensis Georgi. for alleviation of inflammatory cytokines: A comprehensive review
    Hengfeng Liao et al, 2021, Biomedicine & Pharmacotherapy CrossRef
  9. Advances in immunotherapy for the treatment of spinal cord injury
    Abdullah Al Mamun et al, 2021, Immunobiology CrossRef
  10. Wogonoside attenuates the articular cartilage injury and the infiltration of Th1/Th2-type cytokines in papain-induced osteoarthritis in rat model via inhibiting the NF-κB and ERK1/2 activation
    Juan Liu et al, 2021, Immunopharmacology and Immunotoxicology CrossRef
  11. Ornithine decarboxylase (ODC1) gene variant (rs2302615) is associated with gastric cancer independently of Helicobacter pylori CagA serostatus
    Anna K. Miller et al, 2021, Oncogene CrossRef
  12. Promise of the NLRP3 Inflammasome Inhibitors in In Vivo Disease Models
    Biswadeep Das et al, 2021, Molecules CrossRef
  13. The effect of Wogonoside on the expression of TGF-β1/Smad3 in Mycoplasma pneumoniae pneumonia
    Huihui Wang et al, 2021, Pharmacological Research - Modern Chinese Medicine CrossRef
  14. Anti-Inflammatory Effects and Mechanisms of Pudilan Antiphlogistic Oral Liquid
    Gang Tian et al, 2021, ACS Omega CrossRef
  15. Emerging Mechanisms and Targeted Therapy of Pyroptosis in Central Nervous System Trauma
    Biao Yang et al, 2022, Front. Cell Dev. Biol. CrossRef
  16. Neuroinflammation and apoptosis after surgery for a rat model of double-level cervical cord compression
    Min Yao et al, 2022, Neurochemistry International CrossRef
  17. DJ-1 Alleviates Neuroinflammation and the Related Blood-Spinal Cord Barrier Destruction by Suppressing NLRP3 Inflammasome Activation via SOCS1/Rac1/ROS Pathway in a Rat Model of Traumatic Spinal Cord Injury
    Lingxin Cai et al, 2022, JCM CrossRef
  18. Scutellaria baicalensis georgi is a promising candidate for the treatment of autoimmune diseases
    Jun Wang et al, 2022, Front. Pharmacol. CrossRef
  19. A tannic acid doped hydrogel with small extracellular vesicles derived from mesenchymal stem cells promotes spinal cord repair by regulating reactive oxygen species microenvironment
    Zhong Liu et al, 2022, Materials Today Bio CrossRef
  20. An emerging role of inflammasomes in spinal cord injury and spinal cord tumor
    Jiansong Chen et al, 2023, Front. Immunol. CrossRef
  21. Lipocalin-2 Deficiency Diminishes Canonical NLRP3 Inflammasome Formation and IL-1β Production in the Subacute Phase of Spinal Cord Injury
    Nina Müller et al, 2023, IJMS CrossRef
  22. The NF-κB Pathway: a Focus on Inflammatory Responses in Spinal Cord Injury
    Yi Ding et al, 2023, Mol Neurobiol CrossRef
  23. Pharmacological targets at the lysosomal autophagy–NLRP3 inflammasome crossroads
    Srinivasa Reddy Bonam et al, 2023, Trends in Pharmacological Sciences CrossRef
  24. Enzyme-immobilized nanoclay hydrogel simultaneously reduces inflammation and scar deposition to treat spinal cord injury
    Tong Wu et al, 2024, Chemical Engineering Journal CrossRef
  25. The Scutellaria-Coptis herb couple and its active small-molecule ingredient wogonoside alleviate cytokine storm by regulating the CD39/NLRP3/GSDMD signaling pathway
    Huan Wang et al, 2024, Journal of Ethnopharmacology CrossRef
  26. Translational Relevance of Secondary Intracellular Signaling Cascades Following Traumatic Spinal Cord Injury
    Mohammad-Masoud Zavvarian et al, 2024, IJMS CrossRef
  27. Recent advances on signaling pathways and their inhibitors in spinal cord injury
    Yi Ding et al, 2024, Biomedicine & Pharmacotherapy CrossRef